These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29628907)

  • 21. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
    Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
    Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease.
    Loftus AM; Bucks RS; Thomas M; Kane R; Timms C; Barker RA; Gasson N
    J Int Neuropsychol Soc; 2015 Feb; 21(2):137-45. PubMed ID: 25666735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
    Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
    Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Imaging Markers of Prodromal Parkinson's Disease.
    Hustad E; Aasly JO
    Front Neurol; 2020; 11():395. PubMed ID: 32457695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.
    Postuma RB; Pelletier A; Berg D; Gagnon JF; Escudier F; Montplaisir J
    Sleep Med; 2016 May; 21():101-5. PubMed ID: 27448479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement disorder society criteria for clinically established early Parkinson's disease.
    Berg D; Adler CH; Bloem BR; Chan P; Gasser T; Goetz CG; Halliday G; Lang AE; Lewis S; Li Y; Liepelt-Scarfone I; Litvan I; Marek K; Maetzler C; Mi T; Obeso J; Oertel W; Olanow CW; Poewe W; Rios-Romenets S; Schäffer E; Seppi K; Heim B; Slow E; Stern M; Bledsoe IO; Deuschl G; Postuma RB
    Mov Disord; 2018 Oct; 33(10):1643-1646. PubMed ID: 30145841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population.
    de Klerk GW; van Laar T; Meles SK
    NPJ Parkinsons Dis; 2024 Jun; 10(1):125. PubMed ID: 38926405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.
    Khalil H; Chahine LM; Siddiqui J; Salari M; El-Jaafary S; Aldaajani Z; Abu Al-Melh M; Mohammad TM; Abu Snineh M; Syed NA; Bhatt M; Habib MA; Habahbeh M; Tabbal SD; Jeon B; Bajwa JA
    J Parkinsons Dis; 2020; 10(2):729-741. PubMed ID: 32176653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease.
    Giagkou N; Maraki MI; Yannakoulia M; Kosmidis MH; Dardiotis E; Hadjigeorgiou GM; Sakka P; Ntanasi E; Anastasiou CA; Xiromerisiou G; Stefanis L; Scarmeas N; Stamelou M
    Mov Disord; 2020 Oct; 35(10):1802-1809. PubMed ID: 32567751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Atypical' Parkinson's disease - sporadic.
    Zeuner KE; Berg D
    Int Rev Neurobiol; 2019; 149():195-206. PubMed ID: 31779812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.
    Serrano-Dueñas M; Serrano M; Villena D; Granda D
    Mov Disord Clin Pract; 2017; 4(1):51-57. PubMed ID: 30363353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor function and the probability of prodromal Parkinson's disease in older adults.
    Maraki MI; Stefanis L; Yannakoulia M; Kosmidis MH; Xiromerisiou G; Dardiotis E; Hadjigeorgiou GM; Sakka P; Scarmeas N; Stamelou M
    Mov Disord; 2019 Sep; 34(9):1345-1353. PubMed ID: 31314148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
    Friedman JH; Alves G; Hagell P; Marinus J; Marsh L; Martinez-Martin P; Goetz CG; Poewe W; Rascol O; Sampaio C; Stebbins G; Schrag A
    Mov Disord; 2010 May; 25(7):805-22. PubMed ID: 20461797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.